Clinical Trials Browser

Phase 1/2 × Recurrence × Ipilimumab × Clear all

NCT05533697 2026-02-06

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Neoplasm Metastasis, Neoplasms, Recurrence

NCT03233152 2025-11-21

GlitIpNi

Phase 1/2 Active not recruiting

Glioblastoma, Recurrence